A qualitative evaluation of breast cancer survivors’ acceptance of and preferences for consumer wearable technology activity trackers

Nguyen, Nga H.; Hadgraft, Nyssa; Moore, Melissa M.; Rosenberg, Dori E.; Lynch, Chris; Reeves, Marina M.; Lynch, Brigid M.

doi:10.1007/s00520-017-3756-y

Cited by 92 publications

(127 citation statements)

References 24 publications

Supporting

Mentioning

116

Contrasting

Order By: Relevance

“…They used the Polar M400, which their postintervention user survey suggested was challenging to use. Our focus group testing of various commercial devices prior to commencing the ACTIVATE Trial ensured that the wearable we used (the Garmin Vivofit 2) was acceptable to participants …”

Section: Discussionmentioning

confidence: 99%

“…Our focus group testing of various commercial devices prior to commencing the ACTIVATE Trial ensured that the wearable we used (the Garmin Vivofit 2) was acceptable to participants. 28 Wearable technology was also incorporated into a pilot study that aimed to prevent weight gain in African American breast cancer survivors. 19 Participants (n = 35) were randomized to daily self-weighing using smart scales that provided tailored tracking and feedback via an app or website only; daily self-weighing plus physical activity tracking (using a Withings Pulse fitness band); or a control condition.…”

Section: Discussionmentioning

confidence: 99%

“…Participants were provided with a Garmin Vivofit 2 activity monitor, which they were asked to wear for 12 weeks. The selection of this particular device was based on earlier qualitative work . The Garmin Vivofit 2 is worn on the wrist and displays steps, distance, calories, and sleep/rest time.…”

Section: Methodsmentioning

confidence: 99%

“…The selection of this particular device was based on earlier qualitative work. 28 The Garmin Vivofit 2 is worn on the wrist and displays steps, distance, calories, and sleep/rest time. It provides inactivity alerts visually via a red "move" bar on the display and an audible beep.…”

Section: Wearable Technology Activity Monitormentioning

confidence: 99%

See 3 more Smart Citations

A randomized controlled trial of a wearable technology‐based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial

Lynch

Nguyen

Moore

et al. 2019

Cancer

Self Cite

123

177

View full text Add to dashboard Cite

Background The benefits of an active lifestyle after a breast cancer diagnosis are well recognized, but the majority of survivors are insufficiently active. The ACTIVATE Trial examined the efficacy of an intervention (use of the Garmin Vivofit 2 activity monitor coupled with a behavioral feedback and goal‐setting session and 5 telephone‐delivered health coaching sessions) to increase moderate to vigorous physical activity (MVPA) and reduce sedentary behavior in breast cancer survivors. Methods This randomized controlled trial recruited 83 inactive, postmenopausal women diagnosed with stage I‐III breast cancer who had completed primary treatment. Participants were randomly assigned to the intervention group or to the control group, and the intervention was delivered over a 12‐week period. MVPA and sedentary behavior were measured with Actigraph and activPAL accelerometers at baseline (T1) and at the end of the intervention (T2). Results Retention in the trial was high, with 80 (96%) of participants completing T2 data collection. At T2, there was a significant between‐group difference in MVPA (69 min/wk; 95% CI = 22‐116) favoring the intervention group. The trial resulted in a statistically significant decrease in both total sitting time and prolonged bouts (≥20 min) of sitting, with between‐group reductions of 37 min/d (95% CI = −72 to −2) and 42 min/d (95% CI = −83 to −2), respectively, favoring the intervention group. Conclusion Results from the ACTIVATE Trial suggest that the use of wearable technology presents an inexpensive and scalable opportunity to facilitate more active lifestyles for cancer survivors. Whether or not such wearable technology‐based interventions can create sustainable behavioral change should be the subject of future research.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Wearable Technology Activity Monitormentioning

confidence: 99%

See 2 more Smart Citations

A randomized controlled trial of a wearable technology‐based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial

Lynch

Nguyen

Moore

et al. 2019

Cancer

Self Cite

123

177

View full text Add to dashboard Cite

show abstract

“…Brigid Lynch’s Australian group has been able to demonstrate that commercial consumer devices with the associated Fitbit, Jawebone, Garmin, or Polar apps can be used to increase physical activity in postmenopausal breast cancer patients [11]. …”

Section: Ehealth In Therapy Managementmentioning

confidence: 99%

Individualized eHealth Support for Oncological Therapy Management

Schinköthe¹

2019

Breast Care

View full text Add to dashboard Cite

eHealth support for oncological therapy management has different faces. In addition to the direct support of therapy-supportive measures such as the promotion of physical activities, monitoring of the diet and observation of the quality of life through eHealth approaches are possible. Many solutions are now in transition between research and routine use. The most substantial evidence today is in the area of symptom monitoring. Independent studies have shown a significant survival benefit among other advantages as well. There is also a good overlap in eHealth and physical activity. More and more solutions are coming onto the market, which also has an impact for cancer patients. In the field of nutrition, there are only a few successful approaches both within and outside oncology. In contrast, the application of eHealth for the detection of disease-related malnutrition seems promising. Innovative approaches involving “artificial intelligence” or “Internet of Things” are slowly finding their place in both research and routine. For routine care, it will be necessary for doctors, nurses, and patients to know what a real medical eHealth application is and which are just lifestyle products without the needed quality for professional medical usage.

show abstract

Optimization of a technology‐supported physical activity promotion intervention for breast cancer survivors: Results from Fit2Thrive

Penedo

Solk

Siddique

et al. 2021

Cancer

View full text Add to dashboard Cite

BACKGROUND:The benefits of moderate to vigorous physical activity (MVPA) for breast cancer survivors are well established. However, most are insufficiently active. Fit2Thrive used the Multiphase Optimization Strategy methodology to determine the effect of 5 intervention components on MVPA in this population. METHODS: Two hundred sixty-nine participants (mean age, 52.5 years; SD, 9.9 years) received a core intervention (the Fit2Thrive self-monitoring app and Fitbit) and were randomly assigned to 5 intervention components set to on/off in a full factorial experiment: support calls, deluxe app, buddy, online gym, and text messages. The intervention was delivered over 12 weeks with a 12-week follow-up. MVPA was measured via accelerometry at the baseline (T1), at 12 weeks (T2), and at 24 weeks (T3). The main effects and interaction effects at each time point were examined for all components. RESULTS: Trial retention was high: 91.8% had valid accelerometer data at T2 or T3. Across all conditions, there were significant increases in MVPA (+53.6 min/wk; P < .001) and in the proportion of survivors meeting MVPA guidelines (+22.3%; P < .001) at T2 that were maintained but attenuated at T3 (MVPA, +24.6 min/wk; P < .001; meeting guidelines, +12.6%; P < .001). No individual components significantly improved MVPA, although increases were greater for the on level versus the off level for support calls, buddy, and text messages at T2 and T3. CONCLUSIONS: The Fit2Thrive core intervention (the self-monitoring app and Fitbit) is promising for increasing MVPA in breast cancer survivors, but the components provided no additional increases in MVPA. Future research should evaluate the core intervention in a randomized trial and determine what components optimize MVPA behaviors in breast cancer survivors.

show abstract

A qualitative evaluation of breast cancer survivors’ acceptance of and preferences for consumer wearable technology activity trackers

Cited by 92 publications

References 24 publications

A randomized controlled trial of a wearable technology‐based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial

A randomized controlled trial of a wearable technology‐based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial

Individualized eHealth Support for Oncological Therapy Management

Optimization of a technology‐supported physical activity promotion intervention for breast cancer survivors: Results from Fit2Thrive

Contact Info

Product

Resources

About